Clinical Trials on Perineal Laceration in Canada

Total 171 results

University of Manitoba
Riverview Health Centre Foundation

Completed

Treating Foot Drop in People With Multiple Sclerosis Using Electrical Stimulation

Multiple Sclerosis | Foot Drop

Canada
University Health Network, Toronto
University of Alberta; Heart and Stroke Foundation of Canada

Completed

FES in Young Children With Perinatal Stroke

Cerebral Palsy

Canada
ImmunoVaccine Technologies, Inc. (IMV Inc.)

Completed

Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States, Canada
University of Alberta
Alberta Innovates Health Solutions

Completed

Intensive Motor Training After Perinatal Stroke to Enhance Walking

Perinatal Stroke

Canada
Aduro Biotech, Inc.
Incyte Corporation

Terminated

Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer (SEASCAPE)

Platinum-resistant Ovarian Cancer | Platinum-resistant Fallopian Cancer | Platinum-resistant Peritoneal Cancer

United States, Canada
Ludwig-Maximilians - University of Munich
European Union

Completed

Fish Oil and Folate Supplementation During Pregnancy (NUHEAL)

Perinatal DHA and Folate Status | Neurological Development

Hungary, Germany, Spain
University of Calgary

Unknown

Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy (RoboCP)

Hemiplegic Cerebral Palsy | Perinatal Stroke

Canada
University Health Network, Toronto
Bayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaborators

Recruiting

CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) (CARMA-BROS)

Cancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene Mutation

Canada
Hospices Civils de Lyon

Recruiting

ERAS® Guidelines Validation of CRS With or Without HIPEC

Peritoneal Diseases

United States, Canada, Switzerland
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR)

Completed

Efficacy of Physiotherapy for Urinary Incontinence in Women With a Puborectalis Avulsion

Urinary Incontinence | Physiotherapy | Postpartum | Pelvic Floor; Perineal Rupture, Obstetric

Canada
University of Calgary

Completed

Enhancing Motor Plasticity After Perinatal Stroke Using tDCS (tDCS)

Cerebral Palsy | Perinatal Stroke

Canada
University of Calgary
University of Alberta; Heart and Stroke Foundation of Canada

Unknown

Modulation of Brain Plasticity After Perinatal Stroke (PLASTIC CHAMPS)

Stroke | Cerebral Palsy

Canada
Women's College Hospital
Sinai Health System

Completed

Virtual Psychiatric Care for Perinatal Depression (Virtual-PND)

Perinatal Depression

Canada
University of Alberta
Brain Canada

Active, not recruiting

Parent Therapist Partnership to Provide Early, Intensive Exercise in Perinatal Stroke

Perinatal Stroke

Canada
The Canadian College of Naturopathic Medicine
Sunnybrook Health Sciences Centre; Lotte & John Hecht Memorial Foundation

Not yet recruiting

Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome

Perinatal Depression | PerinatalAnxiety

Canada
University of Calgary
The Hospital for Sick Children; University of Alberta; Holland Bloorview Kids...

Completed

Stimulation for Perinatal Stroke Optimizing Recovery Trajectories (SPORT)

Hemiplegic Cerebral Palsy | Perinatal Stroke

Canada
University of Calgary

Active, not recruiting

Home-based Early Intensive Hemiparesis Therapy: Engaging Nurture (HEIGHTEN)

Cerebral Palsy | Perinatal Stroke

Canada
Takeda

Completed

Perianal Fistula (PAF) Validation and Burden of Illness Study

Inflammatory Bowel Disease | Perianal Fistula | Crohns Disease

Canada
The Hospital for Sick Children

Completed

Intermittent Auscultation Using Handheld Doppler: a Randomized Controlled Trial Comparing Perinatal Outcomes in Uganda

Stillbirth | Neonatal Death

Canada, Uganda
St. Joseph's Healthcare Hamilton

Completed

Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19)

Covid19 | Perinatal Anxiety

Canada
ImmunoGen, Inc.

Completed

Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

United States, Spain, Belgium, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
University Health Network, Toronto
Merck Sharp & Dohme LLC; ImmunoVaccine Technologies, Inc. (IMV Inc.)

Active, not recruiting

Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Advanced Cancer | Primary Peritoneal Carcinoma

Canada
Hamilton Health Sciences Corporation

Completed

Postpartum Pelvic Floor Workshop (PPFW)

Pelvic Floor Disorders | Pelvic Floor Muscle Weakness | Pelvic Floor; Incompetency | Perineum; Injury

Canada
Novartis Pharmaceuticals

Completed

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

Netherlands, Canada, United States, Slovakia, United Kingdom
British Columbia Cancer Agency
Ozmosis Research Inc.

Unknown

PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

Canada
Lawson Health Research Institute
Sequana Medical N.V.

Recruiting

Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients (IPUF-HD)

Hemodialysis | Peritoneal Dialysis | End Stage Renal Disease on Dialysis | Nonosmotic Sodium Storage

Canada
University Health Network, Toronto

Withdrawn

Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Endometrioid Tumor | TP53 Mutation

Canada
CHU de Quebec-Universite Laval
Canadian Institutes of Health Research (CIHR); McGill University Health Centre... and other collaborators

Active, not recruiting

Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study

Child Development | Bronchopulmonary Dysplasia | Neonatal and Perinatal Conditions

Canada
Pfizer

Completed

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

United States, Canada
University Health Network, Toronto

Not yet recruiting

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis (CANARY)

End Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney Function

Canada
The Hospital for Sick Children

Not yet recruiting

Early Virtual Intervention for Infants With CP Following HIE Diagnosis (RECOVER)

Cerebral Palsy | Brain Injuries | Hypoxic-Ischemic Encephalopathy | Perinatal Hypoxia

Canada
Hospital Universitario de Fuenlabrada
Instituto de Investigación Hospital Universitario La Paz

Recruiting

Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) (GECOP-MMC)

Colon Cancer | Peritoneal Carcinomatosis

Spain
Maisonneuve-Rosemont Hospital

Completed

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Peritoneal Mesotheliomas

Canada
Mount Sinai Hospital, Canada
Harvard Medical School (HMS and HSDM); Patient-Centered Outcomes Research Institute and other collaborators

Active, not recruiting

Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT) (SUMMIT)

Perinatal Depression

United States, Canada
University of Virginia
National Institute of General Medical Sciences (NIGMS)

Completed

SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection

Peritonitis

United States, Canada
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer

Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer

Canada
University Health Network, Toronto
GlaxoSmithKline

Recruiting

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Canada
Sutro Biopharma, Inc.
GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaborators

Recruiting

REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer

United States, Australia, Korea, Republic of, Israel, Singapore, Canada
GlaxoSmithKline

Completed

Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, Ovarian

United States, Canada
Facet Biotech
Biogen

Terminated

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Peritoneal Neoplasms | Ovarian Cancer

United States, Canada
Begona Martinez de Tejada
Hospital Italiano de Buenos Aires; University of Zurich; University Hospital... and other collaborators

Terminated

Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor (4P)

Preterm Delivery | Morbidity | Perinatal Mortality

Switzerland, Argentina
National Cancer Institute (NCI)

Completed

RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Stage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage IV Primary Peritoneal Cancer

United States, Canada
CASI Pharmaceuticals, Inc.

Completed

Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer

Ovarian Cancer | Peritoneal Cancer | Fallopian Cancer

United States, Canada
Unity Health Toronto

Recruiting

A Non-Traumatic Binder for Temporary Abdominal Wall Closure (ABRO)

Peritonitis | Abdominal Abscess | Abdominal Injury | Abdominal Trauma | Abdominal Sepsis | Abdominal Aneurysm | Abdominal Compartment Syndrome | Abdominal Infection

Canada
Amgen

Completed

TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Switzerland, Korea, Republic of, Russian Federation, Hong Kong, Portugal, South Africa, Israel, Romania, Bulgaria, Greece, Australia, Sweden, Japan, Latvia and more
National Cancer Institute (NCI)

Completed

Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

Recurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...

Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada

Clinical Trials on Perineal Laceration in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations